Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis

References

• Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978; 89: 660–76
   PubMed Web of Science ®Google Scholar
• Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 220: 467–83
   Google Scholar
• Coward RA, Hamdy NAT, Shortland NS, Brown CB. Renal micropolyarteritis: a treatable condition. Nephrol Dial Transplant 1986; 1: 31–7
   PubMedGoogle Scholar
• Fuiano G, Cameron JS, Raftery M, Hartley BH, Williams DG, Ogg CS. Improved prognosis in renal micropolyarteritis in recent years. Nephrol Dial Transplant 1988; 3: 383–91
   PubMed Web of Science ®Google Scholar
• van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; ii: 425–9
   Google Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides; proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–92
   PubMed Web of Science ®Google Scholar
• McLaren JS, McRorie ER, Luqmani RA. Diagnosis and assessment of systemic vasculitis. Clin Exp Rheumatol 2002; 20: 854–62
   PubMedGoogle Scholar
• Spiegelberg HL. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 1974; 19: 259–94
   PubMedGoogle Scholar
• Dechant KL, Brogden RN, Pilkington T, Faulds D. Ifosfamide/mesna; a review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 1991; 42: 428–67
   PubMed Web of Science ®Google Scholar
• Stegmayr BG, Almroth G, Berlin G, Fehrman I, Kurkus J, Norda R, et al. Plasma exchange or immunoadsorption in patients with rapidly progressive glomerulonephritis. A Swedish multi-center study. Int J Artif Organs 1999; 22: 81–7
   PubMed Web of Science ®Google Scholar
• Almroth G, Eneström S, Hed J, Samuelsson I, Sjöström P. Autoantibodies to leucocyte antigens in hydralazine-associated nephritis. J Intern Med 1992; 231: 37–42
   PubMed Web of Science ®Google Scholar
• Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CGM, et al. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicenter study. Rheumatology 2004; 43: 174–80
   PubMed Web of Science ®Google Scholar
• Almroth G, Uhlin F, Ekermo B, Isaksson B, Kaijser B, Andersson B, et al. Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients. Uppsala J Med Sci 2003; 108: 61–74
   PubMed Web of Science ®Google Scholar
• Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005; 257: 540–8
   PubMed Web of Science ®Google Scholar
• Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001; 44: 2836–40
   PubMed Web of Science ®Google Scholar
• Segelmark M, Wieslander J. ANCA and IgG subclasses. Adv Exp Med Biol 1993; 336: 71–5
   PubMedGoogle Scholar
• Westman KW, Selga D, Isberg PE, Bladstrom A, Olsson H. High proteinase 3-antineutrophil cytoplasmic antibody (ANCA)-level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement. J Am Soc Nephrol 2003; 14: 2926–33
   PubMed Web of Science ®Google Scholar
• Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004; 19: 1403–11
   PubMed Web of Science ®Google Scholar
• Bakoush O, Segelmark M, Torffvit O, Ohlsson S, Tencer J. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis. Nephrol Dial Transplant 2006; 21: 1263–9
   PubMed Web of Science ®Google Scholar
• de Groot K, Adu D, Savage COS. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001; 16: 2018–27
   PubMed Web of Science ®Google Scholar
• Vankova’ Z, Rí hová Z, Jancová E, Rysavá R, Merta M, Tesar V. Optimizing the therapeutic strategies in ANCA-associated vasculitis – single centre experience with international randomized trials. Prague Med Rep 2006; 107: 199–212
   PubMedGoogle Scholar
• Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guilllevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18: 2180–8
   PubMed Web of Science ®Google Scholar
• Falk RJ, Lionaki S. Removing antibody and preserving glomeruli in ANCA small vessel vasculitis. J Am Soc Nephrol 2007; 18: 1987–94
   PubMed Web of Science ®Google Scholar
• Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349: 36–44
   PubMed Web of Science ®Google Scholar
• Brouwer E, Cohen Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CG. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991; 83: 379–86
   PubMed Web of Science ®Google Scholar
• Jayne DRW, Weetman AP, Lockwood CM. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991; 84: 476–81
   PubMed Web of Science ®Google Scholar
• Skvaril F. IgG subclasses in viral infections. Basic and clinical aspects of IgG subclasses, F Shakib. Karger, Basel 1986; 134
   Google Scholar
• Lockwood CM, Bowman C, Bakes D, Pressey A, Dash A. Autoimmunity and glomerulonephritis. Adv Nephrol 1987; 16: 291–306
   PubMedGoogle Scholar
• Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663–76
   PubMed Web of Science ®Google Scholar
• Van der Giessen M, Homan WL, van Kernbeek G, Aalberse RC, Dieges PH. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Arch All Appl Immunol 1976; 50: 625–40
   PubMedGoogle Scholar
• Aalberse RC, van der Gaag R, Leeuwen J. Serologic aspect of IgG4 antibodies. J Immunol 1983; 130: 722–6
   PubMed Web of Science ®Google Scholar
• tenBerge IJM, Wilmink JM, Meyer CJLM, Surachno J, ten Veen KH, Balk TG, Schellekens PT. Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis. Am J Nephrol 1985; 5: 21–9
   PubMed Web of Science ®Google Scholar
• Mulder AH, Stegeman CA, Kallenberg CG. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995; 101: 227–32
   PubMed Web of Science ®Google Scholar
• Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible role for the IgG4 subclass. Clin Exp Immunol 2004; 138: 183–92
   PubMed Web of Science ®Google Scholar
• Gao Y, Ye H, Yu F, Guo XH, Zhao MH. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin Immunol 2005; 117: 87–93
   PubMed Web of Science ®Google Scholar
• Hultgren O, Andersson B, Hahn-Zoric M, Almroth G. Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis. Autoimmunity 2007; 40: 529–31
   PubMed Web of Science ®Google Scholar
• Wiedow O, Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 2005; 257: 319–28
   PubMed Web of Science ®Google Scholar
• Hewins P, Morgan MD, Holden N, Neil D, Williams JM, Savage CO, Harper L. IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 2006; 69: 605–15
   PubMed Web of Science ®Google Scholar